Company intelligence / Profile preview

Genovel Orthopedics

Delaware, United States

Ownership: Private
Development stage: Other

Overview

Genovel Orthopedics is developing an early intervention partial knee replacement device designed for patients with early osteoarthritis of the knee. The device consists of uniquely designed femoral and tibial components and targets less invasive, outpatient procedures. Current clinical results have not been published in peer-reviewed sources as of the latest available reports[1][11].

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

New York University (licensing and development agreement)

Beyond the preview

Go deeper on Genovel Orthopedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genovel Orthopedics.

Explore the full profile